The Pretoria High Court has dealt pharmaceutical giant Adcock Ingram a significant blow, ordering the company to cease selling and distributing its new painkiller, Lenbucod. This ruling effectively blocks Adcock Ingram’s Lenbucod from the market. The court found that the name infringed upon rival Aspen Pharmaceuticals’ existing trademark, Mybucod. This legal skirmish between the two JSE-listed heavyweights highlights the increasing…